0NZU.LSE Zealand Pharma A/S

Healthcare Biotechnology London Exchange
- DKK
Market cap
-
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Is 0NZU.LSE undervalued?

Graham number

The Graham number of Zealand Pharma A/S cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Zealand Pharma A/S fundamental analysis

No fundamental analysis for Zealand Pharma A/S yet.

Zealand Pharma A/S stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Zealand Pharma A/S

Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States. The company has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. It also provides Zegalogue, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas sys…

Full company profile